ENCODE cell lines, expression (Ernst 2011)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
BARHL2
|
ENSG00000143032.7 | BARHL2 |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr12_-_91546926 | 2.78 |
ENST00000550758.1 |
DCN |
decorin |
chr12_-_91573132 | 2.44 |
ENST00000550563.1 ENST00000546370.1 |
DCN |
decorin |
chr2_-_238322800 | 2.42 |
ENST00000392004.3 ENST00000433762.1 ENST00000347401.3 ENST00000353578.4 ENST00000346358.4 ENST00000392003.2 |
COL6A3 |
collagen, type VI, alpha 3 |
chr7_-_137028534 | 2.37 |
ENST00000348225.2 |
PTN |
pleiotrophin |
chr2_-_188419078 | 2.29 |
ENST00000437725.1 ENST00000409676.1 ENST00000339091.4 ENST00000420747.1 |
TFPI |
tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor) |
chr13_-_38172863 | 2.27 |
ENST00000541481.1 ENST00000379743.4 ENST00000379742.4 ENST00000379749.4 ENST00000541179.1 ENST00000379747.4 |
POSTN |
periostin, osteoblast specific factor |
chr2_-_238323007 | 2.26 |
ENST00000295550.4 |
COL6A3 |
collagen, type VI, alpha 3 |
chr12_-_91576561 | 2.25 |
ENST00000547568.2 ENST00000552962.1 |
DCN |
decorin |
chr7_-_137028498 | 2.20 |
ENST00000393083.2 |
PTN |
pleiotrophin |
chr12_-_91576429 | 1.94 |
ENST00000552145.1 ENST00000546745.1 |
DCN |
decorin |
chr2_-_238322770 | 1.93 |
ENST00000472056.1 |
COL6A3 |
collagen, type VI, alpha 3 |
chr11_+_101983176 | 1.92 |
ENST00000524575.1 |
YAP1 |
Yes-associated protein 1 |
chr20_+_11898507 | 1.77 |
ENST00000378226.2 |
BTBD3 |
BTB (POZ) domain containing 3 |
chr12_-_89746173 | 1.56 |
ENST00000308385.6 |
DUSP6 |
dual specificity phosphatase 6 |
chr4_+_169418195 | 1.50 |
ENST00000261509.6 ENST00000335742.7 |
PALLD |
palladin, cytoskeletal associated protein |
chr3_-_123339343 | 1.42 |
ENST00000578202.1 |
MYLK |
myosin light chain kinase |
chr19_-_43382142 | 1.40 |
ENST00000597058.1 |
PSG1 |
pregnancy specific beta-1-glycoprotein 1 |
chr6_+_151646800 | 1.33 |
ENST00000354675.6 |
AKAP12 |
A kinase (PRKA) anchor protein 12 |
chr1_-_150780757 | 1.32 |
ENST00000271651.3 |
CTSK |
cathepsin K |
chr15_+_58702742 | 1.30 |
ENST00000356113.6 ENST00000414170.3 |
LIPC |
lipase, hepatic |
chr19_-_43708378 | 1.27 |
ENST00000599746.1 |
PSG4 |
pregnancy specific beta-1-glycoprotein 4 |
chr10_+_7745303 | 1.26 |
ENST00000429820.1 ENST00000379587.4 |
ITIH2 |
inter-alpha-trypsin inhibitor heavy chain 2 |
chr3_-_149095652 | 1.23 |
ENST00000305366.3 |
TM4SF1 |
transmembrane 4 L six family member 1 |
chr11_+_114310164 | 1.22 |
ENST00000544196.1 ENST00000539754.1 ENST00000539275.1 |
REXO2 |
RNA exonuclease 2 |
chr12_-_91505608 | 1.21 |
ENST00000266718.4 |
LUM |
lumican |
chr10_+_94451574 | 1.18 |
ENST00000492654.2 |
HHEX |
hematopoietically expressed homeobox |
chr8_-_49834299 | 1.17 |
ENST00000396822.1 |
SNAI2 |
snail family zinc finger 2 |
chr12_-_12503156 | 1.13 |
ENST00000543314.1 ENST00000396349.3 |
MANSC1 |
MANSC domain containing 1 |
chrX_+_105937068 | 1.12 |
ENST00000324342.3 |
RNF128 |
ring finger protein 128, E3 ubiquitin protein ligase |
chr19_-_6690723 | 1.12 |
ENST00000601008.1 |
C3 |
complement component 3 |
chr5_-_146781153 | 1.08 |
ENST00000520473.1 |
DPYSL3 |
dihydropyrimidinase-like 3 |
chr8_-_49833978 | 1.08 |
ENST00000020945.1 |
SNAI2 |
snail family zinc finger 2 |
chr5_+_76011868 | 1.07 |
ENST00000319211.4 |
F2R |
coagulation factor II (thrombin) receptor |
chr2_+_33359646 | 1.07 |
ENST00000390003.4 ENST00000418533.2 |
LTBP1 |
latent transforming growth factor beta binding protein 1 |
chr7_+_16793160 | 1.04 |
ENST00000262067.4 |
TSPAN13 |
tetraspanin 13 |
chrX_-_114253536 | 1.01 |
ENST00000371936.1 |
IL13RA2 |
interleukin 13 receptor, alpha 2 |
chr5_+_31193847 | 1.00 |
ENST00000514738.1 ENST00000265071.2 |
CDH6 |
cadherin 6, type 2, K-cadherin (fetal kidney) |
chr12_-_51422017 | 1.00 |
ENST00000394904.3 |
SLC11A2 |
solute carrier family 11 (proton-coupled divalent metal ion transporter), member 2 |
chr6_-_134639180 | 0.99 |
ENST00000367858.5 |
SGK1 |
serum/glucocorticoid regulated kinase 1 |
chr11_+_114310102 | 0.96 |
ENST00000265881.5 |
REXO2 |
RNA exonuclease 2 |
chrX_-_130423200 | 0.96 |
ENST00000361420.3 |
IGSF1 |
immunoglobulin superfamily, member 1 |
chr2_-_231989808 | 0.95 |
ENST00000258400.3 |
HTR2B |
5-hydroxytryptamine (serotonin) receptor 2B, G protein-coupled |
chr10_+_7745232 | 0.95 |
ENST00000358415.4 |
ITIH2 |
inter-alpha-trypsin inhibitor heavy chain 2 |
chr18_+_3447572 | 0.90 |
ENST00000548489.2 |
TGIF1 |
TGFB-induced factor homeobox 1 |
chr3_-_165555200 | 0.90 |
ENST00000479451.1 ENST00000540653.1 ENST00000488954.1 ENST00000264381.3 |
BCHE |
butyrylcholinesterase |
chr3_+_132316081 | 0.89 |
ENST00000249887.2 |
ACKR4 |
atypical chemokine receptor 4 |
chr2_+_66662510 | 0.89 |
ENST00000272369.9 ENST00000407092.2 |
MEIS1 |
Meis homeobox 1 |
chr4_+_169418255 | 0.88 |
ENST00000505667.1 ENST00000511948.1 |
PALLD |
palladin, cytoskeletal associated protein |
chr7_+_120702819 | 0.88 |
ENST00000423795.1 |
CPED1 |
cadherin-like and PC-esterase domain containing 1 |
chr1_-_110933663 | 0.87 |
ENST00000369781.4 ENST00000541986.1 ENST00000369779.4 |
SLC16A4 |
solute carrier family 16, member 4 |
chr1_-_110933611 | 0.85 |
ENST00000472422.2 ENST00000437429.2 |
SLC16A4 |
solute carrier family 16, member 4 |
chrX_+_100333709 | 0.84 |
ENST00000372930.4 |
TMEM35 |
transmembrane protein 35 |
chr12_-_103310987 | 0.83 |
ENST00000307000.2 |
PAH |
phenylalanine hydroxylase |
chr18_+_55888767 | 0.82 |
ENST00000431212.2 ENST00000586268.1 ENST00000587190.1 |
NEDD4L |
neural precursor cell expressed, developmentally down-regulated 4-like, E3 ubiquitin protein ligase |
chr10_-_95242044 | 0.81 |
ENST00000371501.4 ENST00000371502.4 ENST00000371489.1 |
MYOF |
myoferlin |
chr4_+_155484155 | 0.80 |
ENST00000509493.1 |
FGB |
fibrinogen beta chain |
chr8_-_23712312 | 0.78 |
ENST00000290271.2 |
STC1 |
stanniocalcin 1 |
chr3_+_52828805 | 0.78 |
ENST00000416872.2 ENST00000449956.2 |
ITIH3 |
inter-alpha-trypsin inhibitor heavy chain 3 |
chr18_-_21977748 | 0.76 |
ENST00000399441.4 ENST00000319481.3 |
OSBPL1A |
oxysterol binding protein-like 1A |
chr3_+_69928256 | 0.75 |
ENST00000394355.2 |
MITF |
microphthalmia-associated transcription factor |
chr17_-_64225508 | 0.74 |
ENST00000205948.6 |
APOH |
apolipoprotein H (beta-2-glycoprotein I) |
chr3_-_149093499 | 0.74 |
ENST00000472441.1 |
TM4SF1 |
transmembrane 4 L six family member 1 |
chr10_-_52645379 | 0.73 |
ENST00000395489.2 |
A1CF |
APOBEC1 complementation factor |
chr2_+_102456277 | 0.73 |
ENST00000421882.1 |
MAP4K4 |
mitogen-activated protein kinase kinase kinase kinase 4 |
chrX_+_46937745 | 0.72 |
ENST00000397180.1 ENST00000457380.1 ENST00000352078.4 |
RGN |
regucalcin |
chr10_-_49813090 | 0.71 |
ENST00000249601.4 |
ARHGAP22 |
Rho GTPase activating protein 22 |
chr15_-_37393406 | 0.68 |
ENST00000338564.5 ENST00000558313.1 ENST00000340545.5 |
MEIS2 |
Meis homeobox 2 |
chr22_-_36357671 | 0.68 |
ENST00000408983.2 |
RBFOX2 |
RNA binding protein, fox-1 homolog (C. elegans) 2 |
chr18_+_55816546 | 0.68 |
ENST00000435432.2 ENST00000357895.5 ENST00000586263.1 |
NEDD4L |
neural precursor cell expressed, developmentally down-regulated 4-like, E3 ubiquitin protein ligase |
chr2_-_20251744 | 0.66 |
ENST00000175091.4 |
LAPTM4A |
lysosomal protein transmembrane 4 alpha |
chr1_-_95391315 | 0.66 |
ENST00000545882.1 ENST00000415017.1 |
CNN3 |
calponin 3, acidic |
chr4_-_110723194 | 0.64 |
ENST00000394635.3 |
CFI |
complement factor I |
chrX_+_67718863 | 0.63 |
ENST00000374622.2 |
YIPF6 |
Yip1 domain family, member 6 |
chr8_+_98881268 | 0.62 |
ENST00000254898.5 ENST00000524308.1 ENST00000522025.2 |
MATN2 |
matrilin 2 |
chrX_+_114827818 | 0.62 |
ENST00000420625.2 |
PLS3 |
plastin 3 |
chr7_+_12727250 | 0.62 |
ENST00000404894.1 |
ARL4A |
ADP-ribosylation factor-like 4A |
chr4_+_74269956 | 0.61 |
ENST00000295897.4 ENST00000415165.2 ENST00000503124.1 ENST00000509063.1 ENST00000401494.3 |
ALB |
albumin |
chr9_-_14180778 | 0.61 |
ENST00000380924.1 ENST00000543693.1 |
NFIB |
nuclear factor I/B |
chr3_+_38017264 | 0.58 |
ENST00000436654.1 |
CTDSPL |
CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase-like |
chr2_+_152214098 | 0.58 |
ENST00000243347.3 |
TNFAIP6 |
tumor necrosis factor, alpha-induced protein 6 |
chr9_+_21409146 | 0.58 |
ENST00000380205.1 |
IFNA8 |
interferon, alpha 8 |
chr2_+_11696464 | 0.57 |
ENST00000234142.5 |
GREB1 |
growth regulation by estrogen in breast cancer 1 |
chr3_-_178984759 | 0.56 |
ENST00000349697.2 ENST00000497599.1 |
KCNMB3 |
potassium large conductance calcium-activated channel, subfamily M beta member 3 |
chr4_-_10686475 | 0.56 |
ENST00000226951.6 |
CLNK |
cytokine-dependent hematopoietic cell linker |
chr3_+_69812701 | 0.54 |
ENST00000472437.1 |
MITF |
microphthalmia-associated transcription factor |
chr8_-_86253888 | 0.54 |
ENST00000522389.1 ENST00000432364.2 ENST00000517618.1 |
CA1 |
carbonic anhydrase I |
chr18_+_29171689 | 0.54 |
ENST00000237014.3 |
TTR |
transthyretin |
chr7_-_27169801 | 0.54 |
ENST00000511914.1 |
HOXA4 |
homeobox A4 |
chr6_+_143929307 | 0.53 |
ENST00000427704.2 ENST00000305766.6 |
PHACTR2 |
phosphatase and actin regulator 2 |
chr4_+_155484103 | 0.53 |
ENST00000302068.4 |
FGB |
fibrinogen beta chain |
chr2_-_183387430 | 0.53 |
ENST00000410103.1 |
PDE1A |
phosphodiesterase 1A, calmodulin-dependent |
chr5_+_140593509 | 0.52 |
ENST00000341948.4 |
PCDHB13 |
protocadherin beta 13 |
chr20_+_4666882 | 0.49 |
ENST00000379440.4 ENST00000430350.2 |
PRNP |
prion protein |
chr12_-_71551868 | 0.49 |
ENST00000247829.3 |
TSPAN8 |
tetraspanin 8 |
chr1_+_203651937 | 0.49 |
ENST00000341360.2 |
ATP2B4 |
ATPase, Ca++ transporting, plasma membrane 4 |
chr4_-_83765613 | 0.49 |
ENST00000503937.1 |
SEC31A |
SEC31 homolog A (S. cerevisiae) |
chr9_-_95244781 | 0.49 |
ENST00000375544.3 ENST00000375543.1 ENST00000395538.3 ENST00000450139.2 |
ASPN |
asporin |
chrX_+_135251783 | 0.48 |
ENST00000394153.2 |
FHL1 |
four and a half LIM domains 1 |
chr12_+_58087901 | 0.48 |
ENST00000315970.7 ENST00000547079.1 ENST00000439210.2 ENST00000389146.6 ENST00000413095.2 ENST00000551035.1 ENST00000257966.8 ENST00000435406.2 ENST00000550372.1 ENST00000389142.5 |
OS9 |
osteosarcoma amplified 9, endoplasmic reticulum lectin |
chr14_+_32798547 | 0.47 |
ENST00000557354.1 ENST00000557102.1 ENST00000557272.1 |
AKAP6 |
A kinase (PRKA) anchor protein 6 |
chr3_+_148709128 | 0.47 |
ENST00000345003.4 ENST00000296048.6 ENST00000483267.1 |
GYG1 |
glycogenin 1 |
chr6_-_49604545 | 0.47 |
ENST00000371175.4 ENST00000229810.7 |
RHAG |
Rh-associated glycoprotein |
chr12_-_53298841 | 0.46 |
ENST00000293308.6 |
KRT8 |
keratin 8 |
chr5_+_95066823 | 0.44 |
ENST00000506817.1 ENST00000379982.3 |
RHOBTB3 |
Rho-related BTB domain containing 3 |
chr2_-_166930131 | 0.43 |
ENST00000303395.4 ENST00000409050.1 ENST00000423058.2 ENST00000375405.3 |
SCN1A |
sodium channel, voltage-gated, type I, alpha subunit |
chrX_-_130423240 | 0.43 |
ENST00000370910.1 ENST00000370901.4 |
IGSF1 |
immunoglobulin superfamily, member 1 |
chrX_+_38660682 | 0.42 |
ENST00000457894.1 |
MID1IP1 |
MID1 interacting protein 1 |
chr19_+_45409011 | 0.42 |
ENST00000252486.4 ENST00000446996.1 ENST00000434152.1 |
APOE |
apolipoprotein E |
chr6_+_167704838 | 0.42 |
ENST00000366829.2 |
UNC93A |
unc-93 homolog A (C. elegans) |
chr5_-_78281603 | 0.41 |
ENST00000264914.4 |
ARSB |
arylsulfatase B |
chr17_+_45726803 | 0.40 |
ENST00000535458.2 ENST00000583648.1 |
KPNB1 |
karyopherin (importin) beta 1 |
chrX_+_38660704 | 0.40 |
ENST00000378474.3 |
MID1IP1 |
MID1 interacting protein 1 |
chr16_-_29910853 | 0.40 |
ENST00000308713.5 |
SEZ6L2 |
seizure related 6 homolog (mouse)-like 2 |
chrX_+_135252050 | 0.40 |
ENST00000449474.1 ENST00000345434.3 |
FHL1 |
four and a half LIM domains 1 |
chr8_+_105352050 | 0.40 |
ENST00000297581.2 |
DCSTAMP |
dendrocyte expressed seven transmembrane protein |
chrX_-_130423386 | 0.39 |
ENST00000370903.3 |
IGSF1 |
immunoglobulin superfamily, member 1 |
chr2_-_55237484 | 0.39 |
ENST00000394609.2 |
RTN4 |
reticulon 4 |
chr7_+_80275953 | 0.39 |
ENST00000538969.1 ENST00000544133.1 ENST00000433696.2 |
CD36 |
CD36 molecule (thrombospondin receptor) |
chr9_-_95298314 | 0.39 |
ENST00000344604.5 ENST00000375540.1 |
ECM2 |
extracellular matrix protein 2, female organ and adipocyte specific |
chr1_-_182360918 | 0.39 |
ENST00000339526.4 |
GLUL |
glutamate-ammonia ligase |
chr14_+_68086515 | 0.38 |
ENST00000261783.3 |
ARG2 |
arginase 2 |
chr20_+_33104199 | 0.38 |
ENST00000357156.2 ENST00000417166.2 ENST00000300469.9 ENST00000374846.3 |
DYNLRB1 |
dynein, light chain, roadblock-type 1 |
chr6_+_167704798 | 0.38 |
ENST00000230256.3 |
UNC93A |
unc-93 homolog A (C. elegans) |
chr2_-_225266743 | 0.37 |
ENST00000409685.3 |
FAM124B |
family with sequence similarity 124B |
chr20_-_47804894 | 0.37 |
ENST00000371828.3 ENST00000371856.2 ENST00000360426.4 ENST00000347458.5 ENST00000340954.7 ENST00000371802.1 ENST00000371792.1 ENST00000437404.2 |
STAU1 |
staufen double-stranded RNA binding protein 1 |
chr8_-_86290333 | 0.37 |
ENST00000521846.1 ENST00000523022.1 ENST00000524324.1 ENST00000519991.1 ENST00000520663.1 ENST00000517590.1 ENST00000522579.1 ENST00000522814.1 ENST00000522662.1 ENST00000523858.1 ENST00000519129.1 |
CA1 |
carbonic anhydrase I |
chr15_-_58571445 | 0.37 |
ENST00000558231.1 |
ALDH1A2 |
aldehyde dehydrogenase 1 family, member A2 |
chr1_+_196788887 | 0.36 |
ENST00000320493.5 ENST00000367424.4 ENST00000367421.3 |
CFHR1 CFHR2 |
complement factor H-related 1 complement factor H-related 2 |
chr5_+_118788182 | 0.36 |
ENST00000515320.1 ENST00000510025.1 |
HSD17B4 |
hydroxysteroid (17-beta) dehydrogenase 4 |
chr13_-_36920872 | 0.36 |
ENST00000451493.1 |
SPG20 |
spastic paraplegia 20 (Troyer syndrome) |
chr7_-_14029283 | 0.36 |
ENST00000433547.1 ENST00000405192.2 |
ETV1 |
ets variant 1 |
chrX_-_105282712 | 0.35 |
ENST00000372563.1 |
SERPINA7 |
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 7 |
chr1_-_182361327 | 0.35 |
ENST00000331872.6 ENST00000311223.5 |
GLUL |
glutamate-ammonia ligase |
chr6_+_26087509 | 0.35 |
ENST00000397022.3 ENST00000353147.5 ENST00000352392.4 ENST00000349999.4 ENST00000317896.7 ENST00000357618.5 ENST00000470149.1 ENST00000336625.8 ENST00000461397.1 ENST00000488199.1 |
HFE |
hemochromatosis |
chr10_-_52645416 | 0.35 |
ENST00000374001.2 ENST00000373997.3 ENST00000373995.3 ENST00000282641.2 ENST00000395495.1 ENST00000414883.1 |
A1CF |
APOBEC1 complementation factor |
chr14_+_105331596 | 0.35 |
ENST00000556508.1 ENST00000414716.3 ENST00000453495.1 ENST00000418279.1 |
CEP170B |
centrosomal protein 170B |
chr14_+_23340822 | 0.35 |
ENST00000359591.4 |
LRP10 |
low density lipoprotein receptor-related protein 10 |
chr7_-_14026123 | 0.34 |
ENST00000420159.2 ENST00000399357.3 ENST00000403527.1 |
ETV1 |
ets variant 1 |
chr12_-_10978957 | 0.34 |
ENST00000240619.2 |
TAS2R10 |
taste receptor, type 2, member 10 |
chr17_-_39093672 | 0.33 |
ENST00000209718.3 ENST00000436344.3 ENST00000485751.1 |
KRT23 |
keratin 23 (histone deacetylase inducible) |
chr1_-_8000872 | 0.33 |
ENST00000377507.3 |
TNFRSF9 |
tumor necrosis factor receptor superfamily, member 9 |
chr7_-_56101826 | 0.33 |
ENST00000421626.1 |
PSPH |
phosphoserine phosphatase |
chr22_-_30960876 | 0.33 |
ENST00000401975.1 ENST00000428682.1 ENST00000423299.1 |
GAL3ST1 |
galactose-3-O-sulfotransferase 1 |
chr9_+_103947311 | 0.33 |
ENST00000395056.2 |
LPPR1 |
Lipid phosphate phosphatase-related protein type 1 |
chr12_-_65146636 | 0.33 |
ENST00000418919.2 |
GNS |
glucosamine (N-acetyl)-6-sulfatase |
chr2_-_162931052 | 0.33 |
ENST00000360534.3 |
DPP4 |
dipeptidyl-peptidase 4 |
chr7_-_99717463 | 0.32 |
ENST00000437822.2 |
TAF6 |
TAF6 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 80kDa |
chr10_-_101825151 | 0.31 |
ENST00000441382.1 |
CPN1 |
carboxypeptidase N, polypeptide 1 |
chr17_-_40288449 | 0.31 |
ENST00000552162.1 ENST00000550504.1 |
RAB5C |
RAB5C, member RAS oncogene family |
chr7_-_2883928 | 0.31 |
ENST00000275364.3 |
GNA12 |
guanine nucleotide binding protein (G protein) alpha 12 |
chr4_+_170541678 | 0.31 |
ENST00000360642.3 ENST00000512813.1 |
CLCN3 |
chloride channel, voltage-sensitive 3 |
chr16_+_69345243 | 0.31 |
ENST00000254950.11 |
VPS4A |
vacuolar protein sorting 4 homolog A (S. cerevisiae) |
chr16_-_53737722 | 0.30 |
ENST00000569716.1 ENST00000562588.1 ENST00000562230.1 ENST00000379925.3 ENST00000563746.1 ENST00000568653.3 |
RPGRIP1L |
RPGRIP1-like |
chr1_-_94586651 | 0.30 |
ENST00000535735.1 ENST00000370225.3 |
ABCA4 |
ATP-binding cassette, sub-family A (ABC1), member 4 |
chr8_-_116681221 | 0.30 |
ENST00000395715.3 |
TRPS1 |
trichorhinophalangeal syndrome I |
chr6_-_8102714 | 0.30 |
ENST00000502429.1 ENST00000429723.2 ENST00000507463.1 ENST00000379715.5 |
EEF1E1 |
eukaryotic translation elongation factor 1 epsilon 1 |
chr19_+_36605850 | 0.29 |
ENST00000221855.3 |
TBCB |
tubulin folding cofactor B |
chr12_+_110011571 | 0.29 |
ENST00000539696.1 ENST00000228510.3 ENST00000392727.3 |
MVK |
mevalonate kinase |
chr2_-_136288113 | 0.29 |
ENST00000401392.1 |
ZRANB3 |
zinc finger, RAN-binding domain containing 3 |
chr7_-_99716952 | 0.29 |
ENST00000523306.1 ENST00000344095.4 ENST00000417349.1 ENST00000493322.1 ENST00000520135.1 ENST00000418432.2 ENST00000460673.2 ENST00000452041.1 ENST00000452438.2 ENST00000451699.1 ENST00000453269.2 |
TAF6 |
TAF6 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 80kDa |
chr4_+_71587669 | 0.29 |
ENST00000381006.3 ENST00000226328.4 |
RUFY3 |
RUN and FYVE domain containing 3 |
chr4_+_170541660 | 0.29 |
ENST00000513761.1 ENST00000347613.4 |
CLCN3 |
chloride channel, voltage-sensitive 3 |
chr16_-_66764119 | 0.29 |
ENST00000569320.1 |
DYNC1LI2 |
dynein, cytoplasmic 1, light intermediate chain 2 |
chr9_-_21202204 | 0.29 |
ENST00000239347.3 |
IFNA7 |
interferon, alpha 7 |
chr1_+_209878182 | 0.29 |
ENST00000367027.3 |
HSD11B1 |
hydroxysteroid (11-beta) dehydrogenase 1 |
chr12_-_71551652 | 0.29 |
ENST00000546561.1 |
TSPAN8 |
tetraspanin 8 |
chr12_-_54694758 | 0.28 |
ENST00000553070.1 |
NFE2 |
nuclear factor, erythroid 2 |
chrX_-_15402498 | 0.28 |
ENST00000297904.3 |
FIGF |
c-fos induced growth factor (vascular endothelial growth factor D) |
chr11_-_72070206 | 0.28 |
ENST00000544382.1 |
CLPB |
ClpB caseinolytic peptidase B homolog (E. coli) |
chr12_-_11062161 | 0.27 |
ENST00000390677.2 |
TAS2R13 |
taste receptor, type 2, member 13 |
chr2_-_225266711 | 0.27 |
ENST00000389874.3 |
FAM124B |
family with sequence similarity 124B |
chr5_-_55412774 | 0.27 |
ENST00000434982.2 |
ANKRD55 |
ankyrin repeat domain 55 |
chr16_-_53737795 | 0.27 |
ENST00000262135.4 ENST00000564374.1 ENST00000566096.1 |
RPGRIP1L |
RPGRIP1-like |
chr4_+_170541835 | 0.27 |
ENST00000504131.2 |
CLCN3 |
chloride channel, voltage-sensitive 3 |
chr12_-_23737534 | 0.26 |
ENST00000396007.2 |
SOX5 |
SRY (sex determining region Y)-box 5 |
chr3_-_47934234 | 0.26 |
ENST00000420772.2 |
MAP4 |
microtubule-associated protein 4 |
chr17_+_66521936 | 0.26 |
ENST00000592800.1 |
PRKAR1A |
protein kinase, cAMP-dependent, regulatory, type I, alpha |
chr3_-_183967296 | 0.26 |
ENST00000455059.1 ENST00000445626.2 |
ALG3 |
ALG3, alpha-1,3- mannosyltransferase |
chr11_+_9406169 | 0.26 |
ENST00000379719.3 ENST00000527431.1 |
IPO7 |
importin 7 |
chr3_-_187009646 | 0.26 |
ENST00000296280.6 ENST00000392470.2 ENST00000169293.6 ENST00000439271.1 ENST00000392472.2 ENST00000392475.2 |
MASP1 |
mannan-binding lectin serine peptidase 1 (C4/C2 activating component of Ra-reactive factor) |
chr7_-_14029515 | 0.26 |
ENST00000430479.1 ENST00000405218.2 ENST00000343495.5 |
ETV1 |
ets variant 1 |
chr17_+_37856299 | 0.26 |
ENST00000269571.5 |
ERBB2 |
v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2 |
chr16_+_72088376 | 0.25 |
ENST00000570083.1 ENST00000355906.5 ENST00000398131.2 ENST00000569639.1 ENST00000564499.1 ENST00000357763.4 ENST00000562526.1 ENST00000565574.1 ENST00000568417.2 ENST00000356967.5 |
HP HPR |
haptoglobin haptoglobin-related protein |
chr16_-_29910365 | 0.25 |
ENST00000346932.5 ENST00000350527.3 ENST00000537485.1 ENST00000568380.1 |
SEZ6L2 |
seizure related 6 homolog (mouse)-like 2 |
chr6_-_131384347 | 0.25 |
ENST00000530481.1 |
EPB41L2 |
erythrocyte membrane protein band 4.1-like 2 |
chr1_-_235814048 | 0.25 |
ENST00000450593.1 ENST00000366598.4 |
GNG4 |
guanine nucleotide binding protein (G protein), gamma 4 |
chr7_-_107443652 | 0.25 |
ENST00000340010.5 ENST00000422236.2 ENST00000453332.1 |
SLC26A3 |
solute carrier family 26 (anion exchanger), member 3 |
chr5_-_125930929 | 0.25 |
ENST00000553117.1 ENST00000447989.2 ENST00000409134.3 |
ALDH7A1 |
aldehyde dehydrogenase 7 family, member A1 |
chr12_-_51402984 | 0.25 |
ENST00000545993.2 |
SLC11A2 |
solute carrier family 11 (proton-coupled divalent metal ion transporter), member 2 |
chrX_+_135251835 | 0.25 |
ENST00000456445.1 |
FHL1 |
four and a half LIM domains 1 |
chr22_+_22599075 | 0.25 |
ENST00000403807.3 |
VPREB1 |
pre-B lymphocyte 1 |
chr1_+_207277590 | 0.25 |
ENST00000367070.3 |
C4BPA |
complement component 4 binding protein, alpha |
chr7_-_14028488 | 0.25 |
ENST00000405358.4 |
ETV1 |
ets variant 1 |
chr4_+_156587853 | 0.25 |
ENST00000506455.1 ENST00000511108.1 |
GUCY1A3 |
guanylate cyclase 1, soluble, alpha 3 |
chr12_-_10962767 | 0.24 |
ENST00000240691.2 |
TAS2R9 |
taste receptor, type 2, member 9 |
chrX_-_153602991 | 0.24 |
ENST00000369850.3 ENST00000422373.1 |
FLNA |
filamin A, alpha |
chr11_-_104035088 | 0.24 |
ENST00000302251.5 |
PDGFD |
platelet derived growth factor D |
chr5_-_148929848 | 0.23 |
ENST00000504676.1 ENST00000515435.1 |
CSNK1A1 |
casein kinase 1, alpha 1 |
chr3_+_138340049 | 0.23 |
ENST00000464668.1 |
FAIM |
Fas apoptotic inhibitory molecule |
chr1_-_150669604 | 0.23 |
ENST00000427665.1 ENST00000540514.1 |
GOLPH3L |
golgi phosphoprotein 3-like |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 16.0 | GO:0005589 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.4 | 1.9 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
0.4 | 1.1 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
0.2 | 1.2 | GO:0070826 | paraferritin complex(GO:0070826) |
0.2 | 0.6 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.1 | 0.4 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
0.1 | 0.5 | GO:0071437 | invadopodium(GO:0071437) |
0.1 | 1.3 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.1 | 1.2 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.1 | 0.7 | GO:0036021 | endolysosome lumen(GO:0036021) |
0.1 | 0.5 | GO:0000836 | Hrd1p ubiquitin ligase complex(GO:0000836) |
0.1 | 1.5 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
0.1 | 0.9 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.1 | 0.6 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.1 | 0.2 | GO:0031523 | Myb complex(GO:0031523) |
0.1 | 7.6 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.1 | 0.2 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.1 | 0.3 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.1 | 0.4 | GO:1990357 | terminal web(GO:1990357) |
0.1 | 0.6 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.0 | 0.6 | GO:0043194 | axon initial segment(GO:0043194) |
0.0 | 0.7 | GO:0097386 | glial cell projection(GO:0097386) |
0.0 | 0.4 | GO:0036157 | outer dynein arm(GO:0036157) |
0.0 | 0.3 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.0 | 0.2 | GO:0097179 | protease inhibitor complex(GO:0097179) |
0.0 | 2.6 | GO:0002102 | podosome(GO:0002102) |
0.0 | 0.9 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.0 | 0.8 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.0 | 0.4 | GO:0005614 | interstitial matrix(GO:0005614) |
0.0 | 1.3 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.0 | 0.9 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.0 | 0.5 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.0 | 0.3 | GO:0043596 | nuclear replication fork(GO:0043596) |
0.0 | 0.1 | GO:0001940 | male pronucleus(GO:0001940) |
0.0 | 0.8 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.0 | 0.6 | GO:0001527 | microfibril(GO:0001527) fibril(GO:0043205) |
0.0 | 1.6 | GO:0005771 | multivesicular body(GO:0005771) |
0.0 | 0.3 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.0 | 1.3 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 1.1 | GO:0031941 | filamentous actin(GO:0031941) |
0.0 | 0.2 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.0 | 0.4 | GO:0042599 | lamellar body(GO:0042599) |
0.0 | 2.0 | GO:0031970 | mitochondrial intermembrane space(GO:0005758) organelle envelope lumen(GO:0031970) |
0.0 | 0.3 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.0 | 0.1 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.0 | 0.5 | GO:0097228 | sperm principal piece(GO:0097228) |
0.0 | 0.1 | GO:0005602 | complement component C1 complex(GO:0005602) |
0.0 | 2.0 | GO:0032432 | actin filament bundle(GO:0032432) |
0.0 | 0.1 | GO:0097443 | sorting endosome(GO:0097443) |
0.0 | 0.2 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.0 | 0.1 | GO:0071439 | clathrin complex(GO:0071439) |
0.0 | 0.2 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.0 | 0.3 | GO:0008091 | spectrin(GO:0008091) |
0.0 | 0.5 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.0 | 0.3 | GO:0097225 | sperm midpiece(GO:0097225) |
0.0 | 0.1 | GO:0042627 | chylomicron(GO:0042627) |
0.0 | 0.1 | GO:0000801 | central element(GO:0000801) |
0.0 | 0.2 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.0 | 0.3 | GO:0097381 | photoreceptor disc membrane(GO:0097381) |
0.0 | 0.5 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.0 | 0.8 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.0 | 0.6 | GO:0055037 | recycling endosome(GO:0055037) |
0.0 | 4.4 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.0 | 0.1 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.0 | 2.5 | GO:0005770 | late endosome(GO:0005770) |
0.0 | 0.3 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.0 | 0.4 | GO:0035579 | specific granule membrane(GO:0035579) |
0.0 | 0.2 | GO:0005922 | connexon complex(GO:0005922) |
0.0 | 0.9 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 0.2 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.0 | 1.5 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 0.2 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.0 | 0.1 | GO:0042382 | paraspeckles(GO:0042382) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 10.4 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 6.6 | NABA COLLAGENS | Genes encoding collagen proteins |
0.1 | 4.1 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.1 | 1.0 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.1 | 1.1 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.0 | 1.1 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.0 | 3.0 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.0 | 2.2 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.0 | 3.5 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.0 | 1.6 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 0.3 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.0 | 1.4 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.0 | 1.3 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.0 | 0.2 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.0 | 1.5 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.0 | 1.1 | PID INSULIN PATHWAY | Insulin Pathway |
0.0 | 0.7 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.0 | 0.3 | PID EPO PATHWAY | EPO signaling pathway |
0.0 | 1.0 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.0 | 0.1 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 1.3 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 1.1 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 4.1 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 1.0 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.0 | 1.3 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.0 | 0.5 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.0 | 0.4 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.0 | 0.1 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.0 | 3.5 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.5 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 0.2 | PID ALK2 PATHWAY | ALK2 signaling events |
0.0 | 0.2 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.0 | 0.4 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.0 | 0.3 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.0 | 1.1 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.0 | 0.5 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.6 | 4.7 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
0.8 | 9.4 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
0.8 | 2.3 | GO:1990523 | bone regeneration(GO:1990523) |
0.8 | 2.3 | GO:0070563 | negative regulation of vitamin D receptor signaling pathway(GO:0070563) |
0.4 | 1.2 | GO:0010621 | negative regulation of transcription by transcription factor localization(GO:0010621) gall bladder development(GO:0061010) |
0.4 | 1.6 | GO:1903224 | regulation of endodermal cell differentiation(GO:1903224) |
0.4 | 1.1 | GO:0002894 | positive regulation of type IIa hypersensitivity(GO:0001798) positive regulation of type II hypersensitivity(GO:0002894) |
0.4 | 1.1 | GO:0099553 | trans-synaptic signaling by lipid, modulating synaptic transmission(GO:0099552) trans-synaptic signaling by endocannabinoid, modulating synaptic transmission(GO:0099553) |
0.3 | 1.5 | GO:2001288 | positive regulation of caveolin-mediated endocytosis(GO:2001288) |
0.3 | 0.9 | GO:0014016 | neuroblast differentiation(GO:0014016) |
0.3 | 2.3 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
0.3 | 1.3 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.2 | 1.2 | GO:0015692 | lead ion transport(GO:0015692) |
0.2 | 0.7 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) negative regulation of DNA catabolic process(GO:1903625) regulation of aminoacyl-tRNA ligase activity(GO:1903630) |
0.2 | 0.6 | GO:0052331 | hemolysis by symbiont of host erythrocytes(GO:0019836) hemolysis in other organism(GO:0044179) hemolysis in other organism involved in symbiotic interaction(GO:0052331) |
0.2 | 1.0 | GO:0010513 | positive regulation of phosphatidylinositol biosynthetic process(GO:0010513) |
0.2 | 1.7 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.2 | 1.1 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.2 | 1.4 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.2 | 0.9 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.2 | 0.7 | GO:0006542 | glutamine biosynthetic process(GO:0006542) |
0.2 | 0.5 | GO:1902938 | regulation of intracellular calcium activated chloride channel activity(GO:1902938) |
0.2 | 0.5 | GO:0033241 | regulation of cellular amine catabolic process(GO:0033241) negative regulation of cellular amine catabolic process(GO:0033242) negative regulation of the force of heart contraction(GO:0098736) regulation of arginine catabolic process(GO:1900081) negative regulation of arginine catabolic process(GO:1900082) regulation of citrulline biosynthetic process(GO:1903248) negative regulation of citrulline biosynthetic process(GO:1903249) negative regulation of cellular amino acid biosynthetic process(GO:2000283) |
0.2 | 0.5 | GO:0070171 | negative regulation of tooth mineralization(GO:0070171) |
0.2 | 0.5 | GO:0035378 | carbon dioxide transmembrane transport(GO:0035378) |
0.2 | 1.2 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.1 | 1.0 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
0.1 | 0.6 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) |
0.1 | 0.4 | GO:1901628 | positive regulation of postsynaptic membrane organization(GO:1901628) |
0.1 | 1.3 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.1 | 0.5 | GO:0031291 | Ran protein signal transduction(GO:0031291) |
0.1 | 1.1 | GO:1904352 | positive regulation of protein catabolic process in the vacuole(GO:1904352) |
0.1 | 0.4 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.1 | 0.4 | GO:0002589 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) negative regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002590) regulation of T cell antigen processing and presentation(GO:0002625) positive regulation of iron ion transport(GO:0034758) positive regulation of iron ion transmembrane transport(GO:0034761) regulation of iron ion import(GO:1900390) regulation of ferrous iron import into cell(GO:1903989) positive regulation of ferrous iron import into cell(GO:1903991) regulation of ferrous iron binding(GO:1904432) positive regulation of ferrous iron binding(GO:1904434) regulation of transferrin receptor binding(GO:1904435) positive regulation of transferrin receptor binding(GO:1904437) regulation of ferrous iron import across plasma membrane(GO:1904438) positive regulation of ferrous iron import across plasma membrane(GO:1904440) response to iron ion starvation(GO:1990641) |
0.1 | 0.7 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.1 | 1.1 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.1 | 1.0 | GO:0043305 | negative regulation of mast cell degranulation(GO:0043305) |
0.1 | 1.0 | GO:0035583 | sequestering of TGFbeta in extracellular matrix(GO:0035583) |
0.1 | 0.3 | GO:0090611 | mitotic cytokinesis checkpoint(GO:0044878) ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
0.1 | 0.7 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.1 | 1.4 | GO:0034372 | very-low-density lipoprotein particle remodeling(GO:0034372) |
0.1 | 0.4 | GO:0072675 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
0.1 | 2.3 | GO:0003334 | keratinocyte development(GO:0003334) |
0.1 | 0.3 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.1 | 1.9 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.1 | 0.4 | GO:0048698 | negative regulation of collateral sprouting in absence of injury(GO:0048698) |
0.1 | 1.3 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.1 | 0.6 | GO:0021740 | trigeminal sensory nucleus development(GO:0021730) principal sensory nucleus of trigeminal nerve development(GO:0021740) negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
0.1 | 0.3 | GO:2000296 | negative regulation of hydrogen peroxide catabolic process(GO:2000296) |
0.1 | 0.3 | GO:0036343 | psychomotor behavior(GO:0036343) |
0.1 | 6.0 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.1 | 0.6 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.1 | 0.8 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.1 | 0.5 | GO:1904153 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.1 | 0.9 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.1 | 0.3 | GO:0030070 | insulin processing(GO:0030070) |
0.1 | 0.1 | GO:2000354 | regulation of ovarian follicle development(GO:2000354) |
0.1 | 0.2 | GO:0070295 | renal water absorption(GO:0070295) |
0.1 | 0.4 | GO:0036111 | very long-chain fatty-acyl-CoA metabolic process(GO:0036111) |
0.1 | 0.4 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.1 | 0.3 | GO:0048478 | replication fork protection(GO:0048478) |
0.1 | 0.5 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.1 | 0.2 | GO:0050955 | thermoception(GO:0050955) |
0.1 | 0.8 | GO:1902221 | L-phenylalanine metabolic process(GO:0006558) L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
0.1 | 0.3 | GO:2001183 | negative regulation of interleukin-10 secretion(GO:2001180) negative regulation of interleukin-12 secretion(GO:2001183) |
0.1 | 0.1 | GO:0060467 | negative regulation of fertilization(GO:0060467) |
0.1 | 0.2 | GO:1901624 | negative regulation of lymphocyte chemotaxis(GO:1901624) |
0.1 | 0.6 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.1 | 1.4 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.1 | 0.5 | GO:0045919 | positive regulation of cytolysis(GO:0045919) |
0.1 | 2.2 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.0 | 0.2 | GO:0090402 | oncogene-induced cell senescence(GO:0090402) |
0.0 | 0.9 | GO:0060044 | negative regulation of cardiac muscle cell proliferation(GO:0060044) |
0.0 | 0.2 | GO:1902748 | positive regulation of lens fiber cell differentiation(GO:1902748) |
0.0 | 1.0 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.0 | 0.4 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
0.0 | 0.2 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.0 | 0.4 | GO:0035799 | ureter maturation(GO:0035799) |
0.0 | 0.7 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
0.0 | 0.3 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
0.0 | 0.3 | GO:0051012 | microtubule sliding(GO:0051012) |
0.0 | 0.1 | GO:0007231 | osmosensory signaling pathway(GO:0007231) |
0.0 | 0.4 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.0 | 0.1 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
0.0 | 0.2 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.0 | 0.2 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.0 | 2.5 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.0 | 0.2 | GO:0052551 | response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
0.0 | 0.4 | GO:0051597 | response to methylmercury(GO:0051597) |
0.0 | 0.2 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.0 | 0.3 | GO:0060154 | response to cycloheximide(GO:0046898) cellular process regulating host cell cycle in response to virus(GO:0060154) |
0.0 | 0.4 | GO:0000050 | urea cycle(GO:0000050) |
0.0 | 0.2 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
0.0 | 0.3 | GO:0019375 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
0.0 | 0.3 | GO:0019532 | oxalate transport(GO:0019532) |
0.0 | 0.3 | GO:0042426 | choline catabolic process(GO:0042426) |
0.0 | 0.1 | GO:0019605 | benzoate metabolic process(GO:0018874) butyrate metabolic process(GO:0019605) |
0.0 | 0.7 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.0 | 0.9 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.0 | 0.3 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
0.0 | 0.1 | GO:0006172 | ADP biosynthetic process(GO:0006172) purine deoxyribonucleoside diphosphate biosynthetic process(GO:0009183) |
0.0 | 0.5 | GO:0042340 | keratan sulfate catabolic process(GO:0042340) |
0.0 | 0.2 | GO:2001106 | regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
0.0 | 0.2 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.0 | 0.3 | GO:0033087 | negative regulation of immature T cell proliferation(GO:0033087) |
0.0 | 0.7 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.0 | 1.5 | GO:0030318 | melanocyte differentiation(GO:0030318) |
0.0 | 0.2 | GO:1904885 | beta-catenin destruction complex assembly(GO:1904885) |
0.0 | 0.2 | GO:1990564 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.0 | 0.1 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.0 | 0.1 | GO:0061441 | vestibulocochlear nerve structural organization(GO:0021649) positive regulation of cytokine activity(GO:0060301) renal artery morphogenesis(GO:0061441) ganglion morphogenesis(GO:0061552) endothelial tip cell fate specification(GO:0097102) VEGF-activated neuropilin signaling pathway involved in axon guidance(GO:1902378) dorsal root ganglion morphogenesis(GO:1904835) otic placode development(GO:1905040) |
0.0 | 0.1 | GO:0071934 | thiamine transport(GO:0015888) thiamine transmembrane transport(GO:0071934) |
0.0 | 0.3 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.0 | 0.1 | GO:0042320 | regulation of circadian sleep/wake cycle, REM sleep(GO:0042320) |
0.0 | 0.2 | GO:0045959 | regulation of complement activation, classical pathway(GO:0030450) negative regulation of complement activation, classical pathway(GO:0045959) regulation of opsonization(GO:1903027) |
0.0 | 0.1 | GO:0060381 | regulation of single-stranded telomeric DNA binding(GO:0060380) positive regulation of single-stranded telomeric DNA binding(GO:0060381) positive regulation of telomeric DNA binding(GO:1904744) |
0.0 | 0.1 | GO:0070092 | response to selenium ion(GO:0010269) regulation of glucagon secretion(GO:0070092) |
0.0 | 0.1 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.0 | 0.2 | GO:0016926 | protein desumoylation(GO:0016926) |
0.0 | 0.3 | GO:0051642 | centrosome localization(GO:0051642) |
0.0 | 0.2 | GO:0009753 | response to jasmonic acid(GO:0009753) cellular response to jasmonic acid stimulus(GO:0071395) |
0.0 | 0.2 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
0.0 | 0.3 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.0 | 0.1 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.0 | 0.0 | GO:0036466 | synaptic vesicle recycling via endosome(GO:0036466) |
0.0 | 0.2 | GO:1905097 | regulation of guanyl-nucleotide exchange factor activity(GO:1905097) |
0.0 | 0.2 | GO:0015846 | polyamine transport(GO:0015846) |
0.0 | 0.3 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.0 | 0.1 | GO:1904749 | regulation of protein localization to nucleolus(GO:1904749) |
0.0 | 0.2 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.0 | 0.5 | GO:0030728 | ovulation(GO:0030728) |
0.0 | 0.3 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
0.0 | 0.2 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.0 | 0.7 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
0.0 | 0.1 | GO:1903301 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
0.0 | 0.0 | GO:0010841 | positive regulation of circadian sleep/wake cycle, wakefulness(GO:0010841) |
0.0 | 0.9 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.0 | 0.2 | GO:0009642 | response to light intensity(GO:0009642) |
0.0 | 0.3 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.0 | 0.7 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.0 | 0.3 | GO:1904776 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
0.0 | 0.9 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.0 | 0.2 | GO:0015865 | purine nucleotide transport(GO:0015865) purine ribonucleotide transport(GO:0015868) |
0.0 | 0.1 | GO:2000048 | interaction with other organism via secreted substance involved in symbiotic interaction(GO:0052047) negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.0 | 0.2 | GO:0072126 | positive regulation of glomerular mesangial cell proliferation(GO:0072126) |
0.0 | 0.1 | GO:1990418 | response to insulin-like growth factor stimulus(GO:1990418) |
0.0 | 0.2 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.0 | 0.4 | GO:0006337 | nucleosome disassembly(GO:0006337) |
0.0 | 0.2 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.0 | 0.1 | GO:0072023 | thick ascending limb development(GO:0072023) metanephric thick ascending limb development(GO:0072233) |
0.0 | 0.2 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
0.0 | 0.1 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
0.0 | 0.1 | GO:0034285 | response to sucrose(GO:0009744) response to disaccharide(GO:0034285) |
0.0 | 0.3 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.0 | 0.5 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.0 | 0.1 | GO:0071300 | cellular response to retinoic acid(GO:0071300) |
0.0 | 0.4 | GO:0008347 | glial cell migration(GO:0008347) |
0.0 | 0.1 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.0 | 0.1 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.0 | 1.1 | GO:0007632 | visual behavior(GO:0007632) |
0.0 | 0.3 | GO:0006704 | glucocorticoid biosynthetic process(GO:0006704) |
0.0 | 0.1 | GO:0010793 | regulation of mRNA export from nucleus(GO:0010793) |
0.0 | 0.1 | GO:0061669 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
0.0 | 0.2 | GO:0070072 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.0 | 0.1 | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
0.0 | 1.6 | GO:0021987 | cerebral cortex development(GO:0021987) |
0.0 | 0.2 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.0 | 0.6 | GO:1900047 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
0.0 | 0.2 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.0 | 0.2 | GO:0033008 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
0.0 | 0.1 | GO:0097283 | keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
0.0 | 0.0 | GO:0060335 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.0 | 0.2 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.0 | 0.1 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.0 | 0.0 | GO:0043012 | regulation of fusion of sperm to egg plasma membrane(GO:0043012) |
0.0 | 0.1 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.0 | 0.1 | GO:0032468 | Golgi calcium ion homeostasis(GO:0032468) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 4.6 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.3 | 1.4 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.2 | 1.2 | GO:0015086 | cadmium ion transmembrane transporter activity(GO:0015086) cobalt ion transmembrane transporter activity(GO:0015087) lead ion transmembrane transporter activity(GO:0015094) ferrous iron uptake transmembrane transporter activity(GO:0015639) |
0.2 | 0.9 | GO:0003990 | acetylcholinesterase activity(GO:0003990) |
0.2 | 1.8 | GO:0034711 | inhibin binding(GO:0034711) |
0.2 | 1.1 | GO:0050436 | microfibril binding(GO:0050436) |
0.2 | 0.8 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.2 | 1.5 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.2 | 1.1 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
0.2 | 1.1 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.2 | 0.7 | GO:0004356 | glutamate-ammonia ligase activity(GO:0004356) ammonia ligase activity(GO:0016211) acid-ammonia (or amide) ligase activity(GO:0016880) |
0.2 | 0.5 | GO:0036487 | nitric-oxide synthase inhibitor activity(GO:0036487) |
0.2 | 0.5 | GO:0035379 | carbon dioxide transmembrane transporter activity(GO:0035379) |
0.1 | 0.7 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.1 | 0.9 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
0.1 | 0.4 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.1 | 8.8 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.1 | 0.4 | GO:0070052 | collagen V binding(GO:0070052) |
0.1 | 2.0 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.1 | 0.5 | GO:0008466 | glycogenin glucosyltransferase activity(GO:0008466) |
0.1 | 0.9 | GO:0004064 | arylesterase activity(GO:0004064) |
0.1 | 12.3 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.1 | 1.6 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.1 | 1.3 | GO:0001968 | fibronectin binding(GO:0001968) |
0.1 | 0.3 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
0.1 | 0.1 | GO:0090079 | translation repressor activity, nucleic acid binding(GO:0000900) translation regulator activity, nucleic acid binding(GO:0090079) |
0.1 | 0.7 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.1 | 1.3 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.1 | 0.3 | GO:0033149 | FFAT motif binding(GO:0033149) |
0.1 | 0.3 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.1 | 0.9 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.1 | 0.3 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.1 | 0.5 | GO:1903135 | cupric ion binding(GO:1903135) |
0.1 | 1.0 | GO:0043176 | amine binding(GO:0043176) serotonin binding(GO:0051378) |
0.1 | 1.7 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.1 | 1.9 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.1 | 0.4 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 1.0 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.1 | 0.3 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
0.1 | 0.2 | GO:0004040 | amidase activity(GO:0004040) fucose binding(GO:0042806) |
0.1 | 1.9 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.1 | 0.2 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.1 | 0.4 | GO:0044594 | 3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity(GO:0033989) 17-beta-hydroxysteroid dehydrogenase (NAD+) activity(GO:0044594) |
0.1 | 0.2 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.1 | 2.2 | GO:0000175 | 3'-5'-exoribonuclease activity(GO:0000175) |
0.1 | 0.2 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
0.1 | 0.5 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.1 | 0.2 | GO:0001071 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
0.1 | 0.7 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.1 | 0.2 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.1 | 0.2 | GO:0070984 | SET domain binding(GO:0070984) |
0.1 | 0.6 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.0 | 0.3 | GO:0050694 | galactosylceramide sulfotransferase activity(GO:0001733) galactose 3-O-sulfotransferase activity(GO:0050694) |
0.0 | 0.2 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.0 | 0.1 | GO:0030366 | molybdopterin synthase activity(GO:0030366) |
0.0 | 0.3 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.0 | 0.4 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.0 | 0.3 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.0 | 0.2 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
0.0 | 0.1 | GO:0017129 | triglyceride binding(GO:0017129) |
0.0 | 1.0 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.0 | 1.5 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.0 | 0.3 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.0 | 0.1 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.0 | 0.1 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.0 | 0.4 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.0 | 0.6 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.0 | 0.9 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.0 | 0.4 | GO:0039706 | co-receptor binding(GO:0039706) |
0.0 | 1.8 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
0.0 | 0.1 | GO:0015403 | thiamine transmembrane transporter activity(GO:0015234) thiamine uptake transmembrane transporter activity(GO:0015403) uptake transmembrane transporter activity(GO:0015563) |
0.0 | 0.3 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.0 | 0.4 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.0 | 0.7 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
0.0 | 0.2 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.0 | 0.3 | GO:0042731 | PH domain binding(GO:0042731) |
0.0 | 0.1 | GO:0003870 | 5-aminolevulinate synthase activity(GO:0003870) N-succinyltransferase activity(GO:0016749) |
0.0 | 0.3 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.0 | 0.2 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.0 | 0.1 | GO:0008336 | gamma-butyrobetaine dioxygenase activity(GO:0008336) |
0.0 | 0.3 | GO:0015643 | toxic substance binding(GO:0015643) |
0.0 | 1.1 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.0 | 0.5 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.0 | 0.1 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
0.0 | 1.1 | GO:0005518 | collagen binding(GO:0005518) |
0.0 | 0.1 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.0 | 0.1 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.0 | 0.2 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.0 | 0.3 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.0 | 0.2 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.0 | 0.1 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.0 | 0.1 | GO:0032190 | acrosin binding(GO:0032190) |
0.0 | 0.2 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.0 | 0.3 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.0 | 0.1 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.0 | 0.3 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.0 | 0.3 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.0 | 0.8 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.0 | 2.3 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.0 | 0.5 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.0 | 0.3 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.0 | 0.1 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.0 | 0.1 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.0 | 0.3 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.0 | 0.2 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.0 | 0.1 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.0 | 0.2 | GO:0050700 | CARD domain binding(GO:0050700) |
0.0 | 0.1 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.0 | 0.2 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.0 | 0.3 | GO:0008603 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.0 | 1.8 | GO:0008201 | heparin binding(GO:0008201) |
0.0 | 1.4 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.0 | 1.3 | GO:0051087 | chaperone binding(GO:0051087) |
0.0 | 0.3 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.0 | 0.0 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.0 | 0.1 | GO:0045029 | UDP-activated nucleotide receptor activity(GO:0045029) |
0.0 | 0.1 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
0.0 | 0.1 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.0 | 0.3 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.0 | 0.0 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.0 | 0.0 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.0 | 0.1 | GO:0016018 | cyclosporin A binding(GO:0016018) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 9.8 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.1 | 1.7 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.1 | 6.6 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 1.6 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.1 | 1.8 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.1 | 3.2 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.1 | 2.0 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.1 | 1.0 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.1 | 0.9 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.1 | 1.6 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.1 | 0.7 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.0 | 0.8 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.0 | 1.8 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.0 | 0.5 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.0 | 1.2 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.0 | 1.1 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.0 | 0.6 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.0 | 1.1 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.0 | 0.5 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.0 | 1.0 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.0 | 1.6 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.0 | 0.8 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.0 | 0.5 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.0 | 0.2 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.0 | 0.2 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.0 | 0.3 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.0 | 0.2 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
0.0 | 0.4 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.0 | 0.0 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.0 | 0.9 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.0 | 0.5 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.0 | 0.2 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.0 | 0.1 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.0 | 0.2 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.0 | 0.3 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.0 | 0.6 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.0 | 0.4 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.0 | 1.0 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.0 | 0.6 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.0 | 0.3 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.0 | 0.2 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.0 | 0.3 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.0 | 1.2 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |